← Open Payments lookup

MARY BRINSFIELD: Open Payments

NPI 1164067476 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$603 in 28 payments from 10 companies in 2025. Trend: 2023 $318 · 2024 $396 · 2025 $603

Food & beverage: $603
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.10$163
E.R. Squibb & Sons, L.L.C.3$141
Teva Pharmaceuticals USA, Inc.4$77
Axsome Therapeutics, Inc.2$51
Janssen Pharmaceuticals, Inc2$43
ABBVIE INC.2$37
Otsuka America Pharmaceutical, Inc.2$34
Lundbeck LLC1$20
Takeda Pharmaceuticals U.S.A., Inc.1$20
Vanda Pharmaceuticals Inc.1$18

Products named: INGREZZA, COBENFY, AUSTEDO XR, REXULTI, Auvelity, INVEGA SUSTENNA, UZEDY, TRINTELLIX.

Industry payments across MD — which companies pay providers there.